Ads
related to: pfizer vaccine
Search results
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 3 days agoOfficials noted that COVID-19 is rapidly evolving. The goal of the group was to capture the virus’...
FDA approves first RSV vaccine for at-risk adults in their 50s
CBS News· 15 hours agoTwo other companies – Pfizer and Moderna – also manufacture RSV vaccines approved for adults 60 and...
What to know about upcoming COVID-19 vaccines and the FLiRT variants
GBH News· 1 day agoThe federal government and vaccine makers are getting a new COVID-19 vaccine ready for the fall. An...
GSK RSV Vaccine Wins US Approval for Younger Age Group
Bloomberg· 16 hours agoHave a confidential tip for our reporters? GSK Plc’s vaccine for respiratory synctial virus was...
The chicken and egg problem of fighting another flu pandemic
Oregon Capital Chronicle via Yahoo News· 2 hours agoEven a peep of news about a new flu pandemic is enough to set scientists clucking about eggs. They...
FDA Panel Recommends New COVID Vaccines For JN.1 Lineage By Fall
Forbes· 3 days agoThe FDA’s independent Vaccines and Related Biological Products Advisory Committee voted unanimously...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 4 days agoOn Monday, Moderna (NASDAQ: MRNA) and Merck & Co (NYSE: MRK) also reported durable efficiency of...
US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59
AOL· 16 hours agoThe shot, branded Arexvy, as well as vaccines from rivals Pfizer and Moderna are already approved for people aged 60 and older for the indication. RSV, ...
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 3 days agoThe FDA approved mRESVIA based on data from a clinical trial that included more than 35,000 adults...
Why Things Could Get Worse for Pfizer Stock Before They Get Better
Motley Fool via Yahoo Finance· 3 days agoA few years ago, in the race to launch a COVID-19 vaccine, Pfizer (NYSE: PFE) stock was a hot buy...